Browsing by Author Ruiz de Porras, Vicenç

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
Apr-2025Bisphenols, PCBs, Parabens, and Dioxins: The Silent Threat of Endocrine Disruptors in Breast CancerSánchez-Ocaña Paz, Marina
21-Sep-2023Curcumin as a hepatoprotective agent against chemotherapy-induced liver injuryRuiz de Porras, Vicenç; Figols, Mariona; Font, Albert; Pardina Arrese, Eva
19-Apr-2016Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathwayRuiz de Porras, Vicenç; Bystrup, Sara; Martínez Cardús, Anna; Pluvinet Ortega, Raquel; Sumoy, Lauro; Howells, Lynne; James, Mark I.; Iwuji, Chinenye; Manzano, José Luis; Layos, Laura; Buges, Cristina; Abad, Albert; Martínez Balibrea, Eva
22-Jan-2024Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancerRuiz de Porras, Vicenç; Bernat Peguera, Adrià; Alcon, Clara; Laguia, Fernando; Fernández Saorin, Maria; Jiménez, Natalia; Senan Salinas, Ana; Solé Blanch, Carme; Feu, Andrea; Marín Aguilera, Mercedes; Pardo, Juan Carlos; Ochoa de Olza, Maria; Montero Boronat, Joan; Mellado González, Begoña; Font, Albert
Jun-2024Investigating the potential role of microplastics and nanoplastics on colorectal cancer development: a proof-of-concept study using HT-29 cellAguayo Rabadan, Carla
1-Jun-2021Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based TreatmentRuiz de Porras, Vicenç; Wang, Xieng Chen; Palomero, Luis; Marin Aguilera, Mercedes; Solé Blanch, Carme; Indacochea, Alberto; Jiménez, Natalia; Bystrup, Sara; Bakht, Martin; Conteduca, Vincenza; Piulats, Josep M.; Buisan, Oscar; Suarez, José F.; Pardo, Juan Carlos; Castro, Elena; Olmos, David; Beltran, Himisha; Mellado González, Begoña; Martínez Balibrea, Eva; Font, Albert; Aytés Meneses, Álvaro
11-Oct-2019Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer PatientsRuiz de Porras, Vicenç; Bystrup, Sara; Cabrero de las Heras, Sara; Musulén, Eva; Palomero, Luis; Alonso Aguado, Maria Henar; Nieto, Rocio; Arango, Diego; Moreno Aguado, Víctor; Queralt, Cristina; Manzano, José Luis; Layos, Laura; Bugés, Cristina; Martínez Balibrea, Eva